Drostanolone Propionate 100 - Androlex

Originally synthesized in the late 1950s but brought to market later, drostanolone propionate filled a specialized role in cancer care. Approved for breast cancer therapy, it was marketed under various names including Drolban and Masteron. As a non-aromatizing androgen, it helped limit estrogen's effects while minimizing masculinizing side effects. Although withdrawn from most medical use by the 1990s, its value was revived in the athletic community, where it’s now prized for creating muscular sharpness and detail without added bulk.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Drostanolone Propionate 100 by Androlex, consult with your doctor or healthcare professional.